Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors (original) (raw)

• Aguirre-Ghiso J, Liu D, Mignatti A, Kovalski K, Ossowski L . (2001). Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12: 863–879.
  Article CAS Google Scholar
• Aguirre-Ghiso J, Estrada Y, Liu D, Ossowski L . (2003). ERKMAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPK. Cancer Res 63: 1684–1695.
  CAS Google Scholar
• Ahmed N, Oliva K, Wang Y, Quinn M, Rice G . (2003). Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–b1 integrin complex in colon cancer cells. Br J Cancer 89: 374–384.
  Article CAS Google Scholar
• Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM et al. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245.
  CAS PubMed Google Scholar
• Allgayer H, Wang H, Gallick GE, Crabtree A, Mazar A, Jones T et al. (1999a). Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (−152/−135) bound with Sp1. J Biol Chem 274: 18428–18437.
  Article CAS Google Scholar
• Allgayer H, Wang H, Shirasawa S, Sasazuki T, Boyd D . (1999b). Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis. Br J Cancer 80: 1884–1891.
  Article CAS Google Scholar
• Allgayer H, Wang H, Wang Y, Heiss MM, Bauer R, Nyormoi O et al. (1999c). Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor. J Biol Chem 274: 4702–4714.
  Article CAS Google Scholar
• Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B . (1998). Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T Cells. J Immunol 161: 243–253.
  Google Scholar
• Bitomsky N, Bohm M, Klempnauer KH . (2004). Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484–7493.
  Article CAS Google Scholar
• Blasi F . (1993). Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 15: 105–111.
  Article CAS Google Scholar
• Boyd D, Brattain M . (1989). Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line. Cancer Res 49: 1948–1953.
  CAS PubMed Google Scholar
• Boyd D, Florent G, Kim P, Brattain M . (1988). Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res 48: 3112–3116.
  CAS PubMed Google Scholar
• Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S et al. (2003). Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. Pathology 200: 640–646.
  Article CAS Google Scholar
• Cmarik J, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H et al. (1999). Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037–14042.
  Article CAS Google Scholar
• Dikic I, Batzer A, Blaikie P, Obermeier A, Ullrich A, Schlessinger J et al. (1995). Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J Biol Chem 270: 15125–15129.
  Article CAS Google Scholar
• Duffy M . (1987). Do proteases play a role in cancer invasion and metastasis? Eur J Cancer Clin Oncol 23: 583–589.
  Article CAS Google Scholar
• Fuchs T, Allgayer H . (2003). Transcriptional regulation of the urokinase receptor (u-PAR)-a central molecule of invasion and metastasis. Biol Chem 384: 755–761.
  Article CAS Google Scholar
• Gallick G, Jessup J . (1992). The biology of colorectal carcinoma. In: Ozols RF, Steele G, Kinsella TJ (eds). Current Problems in Cancer. Mosby Year Book Inc: St Louis, pp 261–328.
  Google Scholar
• Ganesh S, Sier C, Heerding MM, Griffioen G, Lamers CB, Verspaget HW . (1994). Urokinase receptor and colorectal cancer survival. Lancet 344: 401–402.
  Article CAS Google Scholar
• Göke R, Gregel C, Göke A, Arnold R, Schmidt H, Lankat-Buttgereit B . (2004). Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann NY Acad Sci 1014: 220–222.
  Article Google Scholar
• Hapke S, Gawaz M, Dehne K, Kohler J, Marshall JF, Graeff H et al. (2001). beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol Cell Biol 21: 2118–2132.
  Article CAS Google Scholar
• Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW et al. (1995). Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1: 1035–1039.
  Article CAS Google Scholar
• Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U et al. (1996). The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancer. Eur J Surg Oncol 22: 74–77.
  Article CAS Google Scholar
• Janicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Hofler H et al. (1993). Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195–208.
  Article CAS Google Scholar
• Jansen AP, Camalier C, Colburn NH . (2005). Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034–6041.
  Article CAS Google Scholar
• Jansen AP, Camalier CE, Stark C, Colburn NH . (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103–110.
  CAS PubMed Google Scholar
• Kang M, Ahn HS, Lee JY, Matsuhashi S, Park WY . (2002). Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem Biophys Res Commun 293: 617–621.
  Article CAS Google Scholar
• Kim J, Yu W, Kovalski K, Ossowski L . (1998). Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353–362.
  Article CAS Google Scholar
• Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R, Goke R . (2004). Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol 214: 149–153.
  Article CAS Google Scholar
• Lengyel E, Wang H, Stepp E, Juarez J, Wang Y, Doe W et al. (1996). Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J Biol Chem 271: 23176–23184.
  Article CAS Google Scholar
• Monte S, Lahousse SA, Carter J, Wands JR . (2002). ATP luminescence-based motility-invasion assay. BioTechniques 33: 98–106.
  Article Google Scholar
• Muehlenweg B, Sperl S, Magdolen V, Schmitt M, Harbeck N . (2001). Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours. Expert Opin Biol Ther 1: 683–691.
  Article CAS Google Scholar
• Nekarda H, Schmitt M, Ulm K, Wenninger A, Vogelsang H, Becker K et al. (1994). Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res 54: 2900–2907.
  CAS PubMed Google Scholar
• Onishi Y, Kizaki H . (1996). Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 228: 7–13.
  Article CAS Google Scholar
• Onishi Y, Hashimoto S, Kizaki H . (1998). Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215: 453–459.
  Article CAS Google Scholar
• Ossowski L, Clunie G, Masucci MT, Blasi F . (1991). In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 115: 1107–1112.
  Article CAS Google Scholar
• Ossowski L . (1988). In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J Cell Biol 107: 2437–2445.
  Article CAS Google Scholar
• Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y . (2005). Akt Phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65: 11282–11286.
  Article CAS Google Scholar
• Qin H, Sun Y, Benveniste EN . (1999). The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274: 29130–29137.
  Article CAS Google Scholar
• Ritchie S, Boyd F, Wong J, Bonham K . (2000). Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides. J Biol Chem 275: 847–854.
  Article CAS Google Scholar
• Schewe D, Biller T, Maurer G, Asangani IA, Leupold JH, Lengyel E et al. (2005). Combination Analysis of Activator Protein-1FamilyMembers, Sp1 and an Activator Protein-2A-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers. Clin Cancer Res 11: 8538–8548.
  Article CAS Google Scholar
• Schlichter U, Burk O, Worpenberg S, Klempnauer KH . (2001). The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20: 669–676.
  Article Google Scholar
• Shetty S, Kumar A, Idell S . (1997). Post transcriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 17: 1075–1083.
  Article CAS Google Scholar
• Shetty S, Muniyappa H, Halady PKS, Idell S . (2004). Post transcriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Am J Respir Cell Mol Biol 31: 100–106.
  Article CAS Google Scholar
• Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T . (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166: 297–301.
  Article CAS Google Scholar
• Soejima H, Miyoshi O, Yoshinaga H, Masaki Z, Ozaki I, Kajiwara S et al. (1999). Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet Cell Genet 87: 113–114.
  Article CAS Google Scholar
• Stalberg P, Lopez-Egido JR, Wang S, Gobl A, Oberg K, Skogseid B . (2001). Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene. Biochem Biophys Res Commun 281: 227–231.
  Article CAS Google Scholar
• Su K, Roos M, Yang X, Han I, Paterson AJ, Kudlow JE . (1999). An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem 274: 15194–15202.
  Article CAS Google Scholar
• Wagner S, Atkinson M, Thanner S, Wagner C, Schmitt M, Wilhelm O et al. (1995). Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol 147: 183–192.
  CAS PubMed PubMed Central Google Scholar
• Wang H, Skibber J, Juarez J, Boyd D . (1994). Transcriptional activation of the urokinase receptor gene in invasive colon cancer. Int J Cancer 58: 650–657.
  Article CAS Google Scholar
• Wang Y, Dang J, Wang H, Allgayer H, Murrell GA, Boyd D . (2000). Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem 267: 3248–3254.
  Article CAS Google Scholar
• Yang H, Cho M, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH . (2004). A Novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Bio 24: 3894–3906.
  Article CAS Google Scholar
• Yang H, Jansen A, Komar AA, Zheng X, Merrick WC, Costes S et al. (2003a). The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26–37.
  Article Google Scholar
• Yang H, Jansen A, Nair R, Shibahara K, Verma AK, Cmarik JL et al. (2001a). A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kB or ODC transactivation. Oncogene 20: 669–676.
  Article CAS Google Scholar
• Yang H, Knies J, Stark C, Colburn NH . (2003b). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712–3720.
  Article CAS Google Scholar
• Yang H, Matthews C, Clair T, Wang Q, Baker AR, Li CCH et al. (2006). Tumorigenesis suppressor Pdcd4 down-regulates MAP4K1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297–1306.
  Article Google Scholar
• Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE . (2001b). O-linkage of _N_-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98: 6611–6616.
  Article CAS Google Scholar
• Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z . (1999). Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49: 1067–1077.
  Article CAS Google Scholar
• Zakowicz H, Yang H, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn NH . (2005). Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA 11: 261–274.
  Article CAS Google Scholar
• Zhang Z, DuBois R . (2001). Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20: 4450–4456.
  Article CAS Google Scholar
• Zijlstra A, Mellor R, Panzarella G, Aimes RT, Hooper JD, Marchenko ND et al. (2002). A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res 62: 7083–7092.
  CAS PubMed Google Scholar